← Scroll for more →
Financial Statements — AVIR
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 76.55 | 79.32 | 95.71 | 77.34 | 87.72 | 119.39 | 64.70 | 98.46 | 243.39 | 160.91 | 143.82 | 137.89 | 213.70 | 183.26 | 188.46 | 176.41 | 684.48 | 705.55 | 764.38 | 839.66 |
| Accounts Receivable | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.51 | -- | -- | -- | -- |
| Total Current Assets | 228.67 | 263.20 | 310.99 | 336.14 | 385.60 | 433.71 | 462.36 | 486.91 | 506.37 | 548.76 | 590.46 | 603.32 | 620.83 | 632.39 | 660.92 | 681.94 | 689.45 | 713.23 | 772.40 | 842.95 |
| Property, Plant & Equipment | 0.25 | 0.35 | 0.46 | 0.56 | 0.67 | 0.77 | 0.87 | 0.98 | 1.08 | 1.19 | 1.29 | 1.39 | 1.50 | 1.60 | 1.71 | 1.81 | 1.90 | 0.76 | 0.02 | 0.03 |
| Total Non-current Assets* | 3.62 | 3.88 | 4.23 | 6.83 | 6.00 | 6.26 | 2.31 | 4.05 | 4.01 | 4.26 | 4.51 | 4.76 | 5.20 | 5.74 | 5.79 | 4.64 | 4.89 | 3.96 | 0.49 | 0.56 |
| Total Assets | 232.28 | 267.08 | 315.22 | 342.96 | 391.61 | 439.96 | 464.67 | 490.96 | 510.38 | 553.03 | 594.97 | 608.08 | 626.03 | 638.13 | 666.71 | 686.58 | 694.34 | 717.19 | 772.89 | 843.50 |
| Accounts Payable | 10.06 | 9.45 | 12.95 | 3.52 | 8.84 | 7.39 | 4.46 | 5.79 | 5.47 | 21.14 | 4.25 | 0.40 | 3.96 | 0.70 | 2.55 | 1.12 | 13.89 | 3.66 | 4.53 | 22.19 |
| Total Current Liabilities | 28.12 | 33.37 | 39.78 | 20.18 | 20.12 | 21.75 | 18.60 | 25.19 | 26.62 | 41.31 | 32.38 | 18.89 | 16.16 | 12.36 | 18.48 | 15.63 | 25.11 | 28.61 | 56.88 | 262.05 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 | 7.01 | 7.07 | 7.13 | 7.20 | 7.25 | 7.30 | 7.35 | 7.40 | 7.45 | 7.52 | 7.59 | 7.66 | 7.76 | 8.77 | 8.70 | 5.93 | 0.00 |
| Total Liabilities* | 28.12 | 33.37 | 39.78 | 27.18 | 27.19 | 28.88 | 25.80 | 32.44 | 33.91 | 48.66 | 39.78 | 26.35 | 23.68 | 19.95 | 26.14 | 23.39 | 33.88 | 37.31 | 62.82 | 262.05 |
| Retained Earnings | (600.94) | (568.01) | (522.57) | (477.70) | (435.65) | (398.49) | (364.22) | (330.68) | (299.53) | (259.00) | (195.83) | (156.67) | (123.53) | (95.35) | (59.88) | (25.45) | (17.38) | 13.95 | 56.03 | (61.10) |
| Total Stockholder Equity | 204.16 | 233.71 | 275.43 | 315.78 | 364.42 | 411.08 | 438.87 | 458.52 | 476.47 | 504.37 | 555.19 | 581.73 | 602.35 | 618.18 | 640.57 | 663.19 | 660.46 | 679.88 | 710.08 | 581.45 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 192.18 | 32.81 |
| Research & Development | 28.15 | 41.13 | 47.82 | 38.35 | 32.28 | 29.58 | 25.67 | 26.16 | 34.70 | 57.58 | 35.05 | 28.18 | 22.06 | 28.95 | 27.54 | 4.91 | 19.86 | 29.63 | 57.81 | 43.02 |
| Selling, General & Admin | 6.95 | 6.87 | 7.12 | 7.22 | 9.07 | 9.46 | 13.36 | 11.04 | 12.22 | 12.23 | 11.53 | 12.60 | 13.17 | 12.62 | 12.36 | 11.38 | 12.44 | 12.54 | 13.19 | 11.94 |
| Total Operating Expenses | 35.10 | 48.01 | 54.93 | 45.57 | 41.35 | 39.04 | 39.03 | 37.20 | 46.92 | 69.81 | 46.57 | 40.78 | 35.24 | 41.57 | 39.90 | 16.28 | 32.30 | 42.18 | 71.00 | 54.96 |
| Operating Income | (35.10) | (48.01) | (54.93) | (45.57) | (41.34) | (39.04) | (39.03) | (37.20) | (46.92) | (69.81) | (46.57) | (40.78) | (35.23) | (41.57) | (39.90) | (16.28) | (32.29) | (42.17) | 121.18 | (22.15) |
| Pretax Income | (32.91) | (45.39) | (51.63) | (41.85) | (36.95) | (34.07) | (33.32) | (30.92) | (40.28) | (62.94) | (38.81) | (32.92) | (27.93) | (35.27) | (34.31) | (11.90) | (31.21) | (42.08) | 121.23 | (22.09) |
| Tax Provision | 0.02 | 0.05 | (6.77) | 0.20 | 0.21 | 0.20 | 0.23 | 0.23 | 0.24 | 0.23 | 0.35 | 0.22 | 0.25 | 0.20 | 0.12 | (3.83) | 0.12 | -- | 4.10 | 6.10 |
| Net Income | (32.93) | (45.44) | (44.87) | (42.05) | (37.16) | (34.27) | (33.54) | (31.15) | (40.52) | (63.17) | (39.16) | (33.14) | (28.18) | (35.47) | (34.43) | (8.07) | (31.33) | (42.08) | 117.13 | (28.19) |
| Basic EPS | (0.41) | (0.57) | (0.57) | (0.53) | (0.44) | (0.40) | (0.40) | (0.37) | (0.48) | (0.75) | (0.46) | (0.40) | (0.34) | (0.43) | (0.40) | (0.10) | (0.38) | (0.51) | 1.41 | (0.34) |
| Diluted EPS | (0.41) | (0.57) | (0.57) | (0.53) | (0.44) | (0.40) | (0.40) | (0.37) | (0.48) | (0.75) | (0.46) | (0.40) | (0.34) | (0.43) | (0.40) | (0.10) | (0.38) | (0.51) | 1.35 | (0.34) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (37.08) | (46.39) | (28.22) | (40.37) | (32.87) | (30.56) | (30.40) | (23.03) | (42.20) | (39.86) | (21.83) | (17.59) | (16.12) | (29.85) | (21.54) | (21.24) | (19.19) | (59.01) | (75.42) | 22.60 |
| Capital Expenditures | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.02 | 1.88 | 0.04 | -- | -- |
| Free Cash Flow* | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | (21.54) | (21.26) | (21.06) | (59.05) | -- | -- |
| Investing Cash Flow | 34.32 | 29.74 | 46.59 | 41.30 | 15.29 | 85.61 | (3.37) | (122.01) | 124.69 | 56.80 | 27.77 | (58.51) | 46.57 | 24.48 | 33.49 | (486.97) | (1.88) | (0.04) | -- | -- |
| Financing Cash Flow | 0.00 | 0.26 | 0.00 | (11.30) | (14.09) | (0.35) | 0.00 | 0.12 | 0.00 | 0.15 | 0.00 | 0.09 | 0.00 | 0.17 | 0.00 | 0.15 | 0.00 | 0.22 | 0.14 | 0.80 |
← Scroll for more columns →
* Derived from reported values